News
Preliminary applications will only be accepted from February 18 to August 5, 2022. If you plan to submit an IDATA Biospecimen application this cycle, an approved preliminary application is required. Once your preliminary application has been approved, you will be notified and you will be able to continue and submit a full application.
The full application deadline is September 14, 2022. The full applications will undergo panel review and final outcome notifications will be sent by mid-November 2022.
Information is available regarding the IDATA study and IDATA biospecimens.
Please visit the IDATA Application for Biospecimens page to preview instructions about the process, review the IDATA Biospecimen Policies and Procedures, and begin an IDATA Preliminary Application for Biospecimens.
If you have any questions, please contact CDAS staff at cdas-idatabio@imsweb.com
Requests for Specimen Verification will only be accepted from November 15, 2021 to January 13, 2022. If you plan to submit a grant application this cycle, an approved Request for Specimen Verification is required. Once your Request for Specimen Verification has been approved, you will receive a confirmation letter to accompany your grant application.
The grant application deadline is February 11, 2022.
Information is available regarding the PLCO trial and PLCO biospecimens
Please visit the PAR Request Form for Specimen Verification page to preview instructions about the process, review the Policies and Procedures, and begin a Request for Specimen Verification.
If you have any questions, please contact CDAS staff at cdas-eems@imsweb.com.
Preliminary applications will only be accepted from August 21, 2021 to February 17, 2022. If you plan to submit an EEMS application this cycle, an approved preliminary application is required. Once your preliminary application has been approved, you will be notified and you will be able to continue and submit a full application.
The full application deadline is April 1, 2022. The full applications will undergo panel review and final outcome notifications will be sent in early June 2022.
Information is available regarding the PLCO trial and PLCO biospecimens.
Please visit the EEMS Application for Biospecimens page to preview instructions about the process, review the EEMS Policies and Procedures, and begin an EEMS Preliminary Application for Biospecimens.
If you have any questions, please contact CDAS staff at cdas-eems@imsweb.com.
Preliminary applications will only be accepted from August 13, 2021 to February 11, 2022. If you plan to submit an IDATA Biospecimen application this cycle, an approved preliminary application is required. Once your preliminary application has been approved, you will be notified and you will be able to continue and submit a full application.
The full application deadline is March 29, 2022. The full applications will undergo panel review and final outcome notifications will be sent by the end of May 2022.
Information is available regarding the IDATA study and IDATA biospecimens.
Please visit the IDATA Application for Biospecimens page to preview instructions about the process, review the IDATA Biospecimen Policies and Procedures, and begin an IDATA Preliminary Application for Biospecimens.
If you have any questions, please contact CDAS staff at cdas-idatabio@imsweb.com
On August 30, 2021, it will no longer be possible to log in to CDAS via the TCIA Login Service. Affected users will need to log in to CDAS with a different method, such as the IMS Login Service or the NIH Login Service.
If you do not have an IMS or NIH Login Service account, you are advised to create one if you need to access your existing CDAS projects or submit new ones after August 30. You may register for a new IMS Login Service account at the following url: https://help.loginservice.imsweb.com/register?fromURL=https://cdas.cancer.gov/
Once your account is created, you can log in to CDAS with it by clicking "IMS Login Service" on the CDAS login page. If you do not see your existing CDAS projects when logging in with this method, or you have questions or comments, please submit a CDAS Helpdesk Ticket at the following url: https://cdas.cancer.gov/contact/
If you do not wish to create an account at this time, that is okay. You may create an account at any time, even after August 30, and you will be able to access your previous projects.
Thank you for your time. We apologize for any inconvenience.